title: Pulmonary hypertension.
authors.affiliation: Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Hibbert
authors.forename: Rebecca
authors.initials: R
authors.lastname: Hibbert
authors.forename: Trevor
authors.initials: T
authors.lastname: Simard
authors.forename: Carole
authors.initials: C
authors.lastname: Dennie
authors.forename: Edward
authors.initials: E
authors.lastname: O'Brien
mesh_terms: D000280:Administration, Inhalation; D003287:Contrast Media; D005500:Follow-Up Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy*; D021621:Imaging, Three-Dimensional / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000008:administration & dosage; D010092:Oximetry; D010879:Piperazines / Q000008:administration & dosage; D011687:Purines / Q000008:administration & dosage; D011856:Radiographic Image Enhancement; D013902:Radiography, Thoracic; D018570:Risk Assessment; D012720:Severity of Illness Index; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage
chemical_list: D003287:Contrast Media; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D009569:Nitric Oxide; D014859:Warfarin; D000068677:Sildenafil Citrate